These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1354041

  • 1. Preclinical and early clinical studies with BW 1370U87, a reversible competitive MAO-A inhibitor.
    White HL, Ascher JA.
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():343A-344A. PubMed ID: 1354041
    [No Abstract] [Full Text] [Related]

  • 2. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL, Ascher JA.
    Clin Neuropharmacol; 1993; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [Abstract] [Full Text] [Related]

  • 3. A selective, reversible, competitive inhibitor of monoamine oxidase A containing no nitrogen, with negligible potentiation of tyramine-induced blood pressure rise.
    Harfenist M, McGee DP, White HL.
    J Med Chem; 1991 Sep; 34(9):2931-3. PubMed ID: 1895310
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG, McDonald IA, Bey P, Schechter PJ, Sjoerdsma A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Sep; 12(6):967-87. PubMed ID: 3266532
    [Abstract] [Full Text] [Related]

  • 6. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A.
    Acta Physiol Hung; 1990 Sep; 75(4):321-36. PubMed ID: 2127505
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pre-clinical pharmacology of moclobemide. A review of published studies.
    Burkard WP, Da Prada M, Keller HH, Kettler R, Haefely W.
    Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
    [Abstract] [Full Text] [Related]

  • 10. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD.
    Farmakol Toksikol; 1991 Oct; 54(2):38-40. PubMed ID: 1884793
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A, Braibanti E.
    Br J Clin Pharmacol; 1981 Jun; 11(6):605-10. PubMed ID: 7272177
    [Abstract] [Full Text] [Related]

  • 13. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.
    Yamada N, Takahashi S, Todd KG, Baker GB, Paetsch PR.
    J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387
    [Abstract] [Full Text] [Related]

  • 14. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.
    Pickar D, Cohen RM, Jimerson DC, Lake CR, Murphy DL.
    Psychopharmacology (Berl); 1981 Sep; 74(1):8-12. PubMed ID: 6791210
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
    Palfreyman MG, McDonald IA, Fozard JR, Mely Y, Sleight AJ, Zreika M, Wagner J, Bey P, Lewis PJ.
    J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
    [Abstract] [Full Text] [Related]

  • 16. Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.
    Pickar D, Cohen RM, Jimerson DC, Murphy DL.
    Psychopharmacology (Berl); 1981 Dec; 74(1):4-7. PubMed ID: 6791202
    [Abstract] [Full Text] [Related]

  • 17. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M, Gorodetsky E, Wang RH, Gross A, Weinreb O, Youdim MB.
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR, Firkusny L, Schick C, Antonin KH, Nilsson E, Schulz R, Schwenk M, Wollmann H.
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [Abstract] [Full Text] [Related]

  • 19. [Monoamine oxidase inhibitory effects of pentanthrene type heterocyclic compounds].
    Noda A, Noda H, Imamura T, Ono Y, Morita M, Kai M, Mine S, Goto S.
    Yakugaku Zasshi; 1991 Sep; 111(9):499-503. PubMed ID: 1762051
    [Abstract] [Full Text] [Related]

  • 20. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
    Youdim MB.
    J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.